β3肾上腺素能受体：眼科的药物靶点？ - Suppr

β3-adrenoceptors: a drug target in ophthalmology?

作者信息

Gericke Adrian, Böhmer Tobias, Michel Martin C

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):265-7. doi: 10.1007/s00210-013-0835-6. Epub 2013 Jan 24.

DOI:10.1007/s00210-013-0835-6

PMID:23344523

Abstract

摘要

相似文献

β3-adrenoceptors: a drug target in ophthalmology?

Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):265-7. doi: 10.1007/s00210-013-0835-6. Epub 2013 Jan 24.

β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β -adrenoceptors.

Br J Pharmacol. 2019 Jul;176(14):2496-2508. doi: 10.1111/bph.14552. Epub 2018 Dec 18.

Effects of beta3-adrenoceptor activation on the interaction between adrenoceptors and angiotensin II receptors in apolipoprotein E knockout mouse lung.

Eur J Pharmacol. 2014 Nov 5;742:75-80. doi: 10.1016/j.ejphar.2014.09.007. Epub 2014 Sep 16.

Further characterization of beta3-adrenoceptors in the guinea pig gastric fundus: stereoselectivity, beta-adrenoceptor alkylation, and structure-activity relationship.

Can J Physiol Pharmacol. 2001 Dec;79(12):985-95.

The new radioligand [(3)H]-L 748,337 differentially labels human and rat β3-adrenoceptors.

Eur J Pharmacol. 2013 Nov 15;720(1-3):124-30. doi: 10.1016/j.ejphar.2013.10.039. Epub 2013 Oct 29.

Binding properties of beta-blockers at recombinant beta1-, beta2-, and beta3-adrenoceptors.

J Cardiovasc Pharmacol. 2000 Oct;36(4):466-71. doi: 10.1097/00005344-200010000-00008.

Agonist-induced desensitisation of β -adrenoceptors: Where, when, and how?

Br J Pharmacol. 2019 Jul;176(14):2539-2558. doi: 10.1111/bph.14633. Epub 2019 Apr 7.

Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):269-78. doi: 10.1007/s00210-012-0828-x. Epub 2013 Jan 3.

β -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions?

Br J Pharmacol. 2019 Jul;176(14):2525-2538. doi: 10.1111/bph.14658. Epub 2019 May 3.

β3-Adrenoceptor-mediated responses in diabetic rat heart.

Gen Physiol Biophys. 2014;33(1):99-109. doi: 10.4149/gpb_2013065. Epub 2013 Dec 13.

引用本文的文献

Adrenoceptors in the Eye - Physiological and Pathophysiological Relevance.

Handb Exp Pharmacol. 2024;285:453-505. doi: 10.1007/164_2023_702.

β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases-Historical Aspects and Nowadays Understanding.

Int J Mol Sci. 2023 Feb 28;24(5):4698. doi: 10.3390/ijms24054698.

HIF-1-Dependent Induction of β3 Adrenoceptor: Evidence from the Mouse Retina.

Cells. 2022 Apr 8;11(8):1271. doi: 10.3390/cells11081271.

Evaluation of the Effect of a Novel β3-Adrenergic Agonist on Choroidal Vascularity.

Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):17. doi: 10.1167/iovs.62.9.17.

Upregulation of β-adrenoceptors-a general marker of and protective mechanism against hypoxia?

Naunyn Schmiedebergs Arch Pharmacol. 2020 Feb;393(2):141-146. doi: 10.1007/s00210-019-01780-6. Epub 2019 Dec 18.

本文引用的文献

Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):269-78. doi: 10.1007/s00210-012-0828-x. Epub 2013 Jan 3.

Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.

Eur Urol. 2013 Feb;63(2):283-95. doi: 10.1016/j.eururo.2012.10.016. Epub 2012 Nov 6.

Protective effects of the β3-adrenoceptor agonist CL316243 against N-methyl-D-aspartate-induced retinal neurotoxicity.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Nov;385(11):1077-81. doi: 10.1007/s00210-012-0796-1. Epub 2012 Sep 11.

A multicenter, double-blind, randomized, placebo-controlled trial of the β3-adrenoceptor agonist solabegron for overactive bladder.

Eur Urol. 2012 Nov;62(5):834-40. doi: 10.1016/j.eururo.2012.05.053. Epub 2012 Jun 5.

Specificity evaluation of antibodies against human β3-adrenoceptors.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Sep;385(9):875-82. doi: 10.1007/s00210-012-0767-6. Epub 2012 Jun 12.

Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy.

Invest Ophthalmol Vis Sci. 2012 May 17;53(6):2968-77. doi: 10.1167/iovs.12-9691.

Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity.

Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2181-92. doi: 10.1167/iovs.11-9408.

Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia.

Naunyn Schmiedebergs Arch Pharmacol. 2012 May;385(5):481-94. doi: 10.1007/s00210-012-0735-1. Epub 2012 Feb 7.

Role of β3-adrenoceptors in regulation of retinal vascular tone in rats.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Dec;384(6):603-8. doi: 10.1007/s00210-011-0682-2. Epub 2011 Sep 8.

Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Jun;383(6):593-612. doi: 10.1007/s00210-011-0625-y. Epub 2011 Apr 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

β3-adrenoceptors: a drug target in ophthalmology?

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

β3-adrenoceptors: a drug target in ophthalmology?

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献